Q1 2022 EPS Estimates for UpHealth, Inc. (NYSE:UPH) Decreased by Oppenheimer

UpHealth, Inc. (NYSE:UPHGet Rating) – Equities research analysts at Oppenheimer decreased their Q1 2022 earnings per share (EPS) estimates for UpHealth in a research report issued to clients and investors on Monday, April 18th. Oppenheimer analyst M. Wiederhorn now forecasts that the company will earn ($0.06) per share for the quarter, down from their prior forecast of ($0.05). Oppenheimer also issued estimates for UpHealth’s Q3 2022 earnings at ($0.02) EPS, Q4 2022 earnings at ($0.01) EPS, FY2022 earnings at ($0.14) EPS, FY2023 earnings at ($0.06) EPS and FY2024 earnings at $0.01 EPS.

A number of other equities research analysts have also recently issued reports on the company. Zacks Investment Research upgraded UpHealth from a “sell” rating to a “hold” rating in a report on Wednesday. Lake Street Capital downgraded UpHealth from a “buy” rating to a “hold” rating in a research report on Thursday, March 31st. Finally, Northland Securities dropped their price target on shares of UpHealth from $10.50 to $4.50 and set an “outperform” rating on the stock in a research report on Thursday, March 31st. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $9.63.

NYSE:UPH opened at $1.00 on Thursday. The company has a current ratio of 1.12, a quick ratio of 1.09 and a debt-to-equity ratio of 0.16. UpHealth has a 52-week low of $0.91 and a 52-week high of $10.72. The stock has a 50-day simple moving average of $1.85 and a 200 day simple moving average of $2.20.

A number of large investors have recently made changes to their positions in the stock. Lynrock Lake LP purchased a new stake in UpHealth in the fourth quarter worth $2,837,000. Perkins Capital Management Inc. bought a new position in UpHealth during the 4th quarter valued at about $2,104,000. Omni Event Management Ltd bought a new position in shares of UpHealth during the 4th quarter valued at $1,681,000. Renaissance Technologies LLC increased its position in shares of UpHealth by 409.5% during the 4th quarter. Renaissance Technologies LLC now owns 784,107 shares of the company’s stock valued at $1,756,000 after purchasing an additional 630,207 shares during the last quarter. Finally, Geode Capital Management LLC purchased a new position in shares of UpHealth during the 4th quarter worth $1,394,000. Institutional investors own 6.46% of the company’s stock.

UpHealth Company Profile (Get Rating)

UpHealth, Inc operates as a digital health services company. It provides patient-centric digital health platform and tech-enabled services to manage health and integrate care. The company's solutions include Syntranet Core Platform, an integrated care management platform; Global Telemedicine; MedQuest Digital Pharmacy, a full-service pharmacy that offers manufactured medication, custom compounded medications, nutraceuticals, lab testing, advocacy, education, etc.; and Behavioral Telehealth solutions.

Featured Articles

Earnings History and Estimates for UpHealth (NYSE:UPH)

Receive News & Ratings for UpHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UpHealth and related companies with MarketBeat.com's FREE daily email newsletter.